ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmes, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmes, E. C.

The Annals of Thoracic Surgery, Vol 21, 250-258, Copyright © 1976 by The Society of Thoracic Surgeons

ARTICLES

Immunology and lung cancer

EC Holmes

Carcinoma of the lung is the number one cancer killer in the United States. The overall cure rate is about 10%, and although resection is the best treatment available, five-year survival following operation is only 25%. Recent studies have shown that patients with lung cancer are immunosuppressed but that pulmonary tumors do contain tumor-associated antigens. Studies of other human tumors indicate that immunotherapy can augment tumor immunity and can be an effective surgical adjuvant. This communication reviews the basic principles of tumor immunology, with emphasis on the immunology of lung cancer, and discusses how these principles may be applied to the therapy of lung cancer.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1976 by The Society of Thoracic Surgeons.